You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Farnesoid X receptor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Human Immunodeficiency Virus I Infection Trial in Lyon (Blood collection.)

Not yet recruiting
  • Human Immunodeficiency Virus I Infection
  • Blood collection.
  • Lyon, France
    Service des maladies infectieuses et tropicales Hôpital de la Cr
Jan 21, 2022

Farnesoid X Receptor Ligands on Reactivation of Latent Provirus

Completed
  • Hiv
  • Blood sampling
  • Lyon, France
    Service des maladies infectieuses et tropicales - Hôpital de la
Jul 28, 2021

Hepatitis B, Chronic Trial in Hong Kong, Korea, Republic of, Taiwan (EYP001a, Entecavir, Pegylated interferon alpha2a)

Active, not recruiting
  • Hepatitis B, Chronic
  • Hong Kong, Hong Kong
  • +5 more
Sep 27, 2021

Obesity Trial in Göteborg (Obeticholic acid, Obeticholic acid )

Unknown status
  • Obesity
  • Obeticholic acid
  • Obeticholic acid placebo
  • Göteborg, Sweden
  • +1 more
Aug 22, 2020

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Chronic GVHD, Hematologic and Lymphocytic Disorder, Steroid Refractory GVHD Trial in Duarte (procedure, biological, other)

Not yet recruiting
  • Chronic Graft Versus Host Disease
  • +2 more
  • Biopsy
  • +11 more
  • Duarte, California
    City of Hope Medical Center
Aug 7, 2023

Cough Trial (device, diagnostic test, procedure)

Not yet recruiting
  • Cough
  • Adenosine triphosphate (ATP) solution inhalation from nebuliser
  • +7 more
  • (no location specified)
Jan 26, 2023

Glioblastoma Trial (PET imaging)

Not yet recruiting
  • Glioblastoma
  • PET imaging
  • (no location specified)
Feb 23, 2023

Healthy Trial in Leuven (Ocaliva, Placebo)

Recruiting
  • Healthy
  • Leuven, Vlaams-Brabant, Belgium
    KU Leuven
Feb 13, 2023

Postpartum Hemorrhage Trial in Toronto (Oxytocin)

Recruiting
  • Postpartum Hemorrhage
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
Oct 24, 2022

Non-Hodgkin Lymphoma Trial in Aurora (CD19x22 CAR T Cells)

Active, not recruiting
  • Non-Hodgkin Lymphoma
  • CD19x22 CAR T Cells
  • Aurora, Colorado
    University of Colorado Hospital
Sep 1, 2022

Non-Alcoholic Fatty Liver Disease Trial in Dhaka (Obeticholic acid)

Completed
  • Non-Alcoholic Fatty Liver Disease
  • Obeticholic acid
  • Dhaka, Bangladesh
    Department of Hepatology
May 15, 2022

PFS Trial in Qingdao (afatinib)

Recruiting
  • PFS
  • Qingdao, Shandong, China
  • +1 more
Feb 23, 2022

Type 2 Diabetes, Obesity Trial in Sherbrooke (drug, other, diagnostic test, procedure)

Recruiting
  • Type 2 Diabetes
  • Obesity
  • Formoterol Fumarate 12 micrograms Inhalation Powder
  • +8 more
  • Sherbrooke, Quebec, Canada
    Centre de recherche du CHUS
Sep 22, 2022

Non-alcoholic Steatohepatitis Trial in Tanta (Obeticholic Acid Oral Tablet, Vit E)

Active, not recruiting
  • Non-alcoholic Steatohepatitis
  • Obeticholic Acid Oral Tablet
  • Vit E
  • Tanta, Egypt
    Department of Tropical Medicine and Infectious Diseases, Faculty
Oct 6, 2022

Healthy Participants Trial in Glendale (ID119031166M, Placebo)

Recruiting
  • Healthy Participants
  • Glendale, California
    California Clinical trials medical group/PAREXEL
Oct 28, 2022

COVID-19 Respiratory Infection Trial in Lublin (Xanthohumol - prenylated chalcone extracted from female inflorescences of hop

Suspended
  • COVID-19 Respiratory Infection
  • Xanthohumol - prenylated chalcone extracted from female inflorescences of hop cones (Humulus lupus). Hop-RXn™, BioActive-Tech Ltd, Lublin, Poland; http://xanthohumol.com.pl/
  • Lublin, Poland
    Medical University of Lublin
Jul 15, 2022

Liver X Receptor asNovel Therapeutic Target in Diabetic

Recruiting
  • Diabetic Retinopathy
  • blood draw
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 13, 2021

Drug-Induced Liver Injury, Cholestatic Liver Injury, Mixed Liver Injury Trial in Shanghai (MT2004 Capsule, MT2004 Capsule

Recruiting
  • Drug-Induced Liver Injury
  • +2 more
  • MT2004 Capsule
  • MT2004 Capsule Placebo
  • Shanghai, Shanghai, China
    Shanghai Jiaotong University School of Medicine,Renji Hospital
Aug 25, 2023

Metastatic Pancreatic Ductal Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial

Not yet recruiting
  • Metastatic Pancreatic Ductal Adenocarcinoma
  • +3 more
  • Biopsy
  • +8 more
  • (no location specified)
Jan 13, 2023

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Adenocarcinoma Trial in New York, Providence (Motixafortide, Cemiplimab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • New York, New York
  • +1 more
Nov 7, 2022

Non-Alcoholic Fatty Liver Disease Trial in Porto (BAR502, Placebo)

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • Porto, Portugal
    BlueClinical Phase I
Jan 5, 2022

Colorectal Cancer Trial in Duarte (biological, drug, genetic, other, procedure)

Active, not recruiting
  • Colorectal Cancer
  • bevacizumab
  • +13 more
  • Duarte, California
    City of Hope Medical Center
Sep 3, 2021

NSCLC, EGFR G719X, EGFR L861Q Trial in Chongqing (Furmonertinib 160 mg, Q.D.)

Recruiting
  • Non-small Cell Lung Cancer
  • +3 more
  • Furmonertinib 160 mg, Q.D.
  • Chongqing, Chongqing, China
  • +2 more
Sep 16, 2022

Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)

Recruiting
  • Adamantinomatous Craniopharyngioma
  • Recurrent Adamantinomatous Craniopharyngioma
  • Aurora, Colorado
  • +17 more
Jan 8, 2023